F. Bien, T. Ziegler / Tetrahedron: Asymmetry 9 (1998) 781–790
787
3.11. (S)-2-Benzoyloxy-4-pentene-1-ol (S)-(8)
Treatment of (S)-7 (900 mg, 2.58 mmol) as described for compound (R)-7 afforded (S)-8 (516 mg,
97%); [α]2D0=−9.7 (c=2.1, CHCl3).
3.12. 2,3,4,6-Tetra-O-benzoyl-α-D-mannopyranosyl trichloroacetimidate 9
DBU (500 µl, 3.40 mmol) was added to a solution of trichloroacetonitrile (6.7 ml, 67 mmol) and
2,3,4,6-tetra-O-benzoyl-D-mannopyranose14 (20.0 g, 33.5 mmol) in CH2Cl2 (150 ml) and the mixture
was stirred for 2 h at 0°C. The mixture was concentrated and the residue was chromatographed
(petroleum ether:ethyl acetate=2:1 with 1% Et3N) to afford 9 (18.62 g, 75%); [α]2D0=−37 (c=1.5,
1
CHCl3); H NMR (300 MHz): δ=4.62 (dd, 1H, 6-Hb, J5,6b=4.1 Hz, J6a,6b=12.2 Hz), 4.61–4.67 (m,
1H, 5-H), 4.74 (dd, 1H, 6-Ha; J5,6a=2.4 Hz), 5.95 (dd, 1H, 2-H, J1,2=1.9 Hz, J2,3=3.3 Hz), 5.99 (dd,
1H, 3-H, J3,4=9.9 Hz), 6.24 (1H, 4-H, J4,5=10.0 Hz), 6.58 (d, 1H, 1-H), 7.24–8.11 (m, 20H, C6H5),
8.87 (s, 1H, CNHCCl3); 13C NMR (75.5 MHz): δ=62.4 (C-6), 66.1 (C-4), 68.9 (C-3), 69.8 (C-2), 71.6
(C-5), 90.6 (CNHCCl3), 94.7 (C-1), 159.9 (CNHCCl3), 165.1, 165.4, 165.5, 166.0 (CO); anal. calcd for
C36H28NO10Cl3 (741.0): C, 58.43; H, 3.81; N, 1.89; Cl, 14.35; found: C, 58.49; H, 3.95; N, 1.64; Cl,
14.54.
3.13. (S)-2-Benzoyloxy-4-pentene-1-yl 2,3,4,6-tetra-O-benzoyl-α-D-mannopyranoside 10
A solution of TMSOTf (91 µl, 0.5 mmol) in CH2Cl2 (10 ml) was added at −30°C to a solution of (S)-8
(969 mg, 4.70 mmol) and 9 (3.60 g, 4.86 mmol) in CH2Cl2 (50 ml). After stirring for 50 min, the mixture
was neutralized with pyridine, filtered, washed with aq. 2 M HCl and NaHCO3 solution, dried (Na2SO4)
and concentrated. Chromatography (CCl4:acetone=15:1) of the residue afforded 10 (3.63 g, 98%), which
was crystallized from petroleum ether–acetone; mp: 114–116°C; [α]2D0=−27 (c=1.2, CHCl3); 1H NMR
(500 MHz): δ=2.59–2.66 (t, 2H, 31-Ha, 31-Hb), 3.82 (dd, 1H, 11-Hb, J11b,21=4.0 Hz, J11a,11b=10.6 Hz),
4.07 (dd, 1H, 11-Ha, J11a,21=6.1 Hz), 4.40–4.46 (m, 2H, 52-H, 62-Hb), 4.66–4.69 (m, 1H, 62-Ha), 5.15
(dd, 1H, 51-Hcis, J41,51cis=10.3 Hz, J51cis,51trans=1.3 Hz), 5.17 (d, 1H, 12-H, J12,22=1.5 Hz). 5.23 (dd, 1H,
51-Htrans, J41,51trans=17.1 Hz), 5.46–5.50 (m, 1H, 21-H), 5.76 (dd, 1H, 22-H, J22,32=3.1 Hz), 5.85 (dd,
1H, 32-H, J32,42=10.1 Hz), 5.87–5.93 (m, 1H, 41-H), 6.08 (t, 1H, 42-H); 13C NMR (125 MHz): δ=35.6
(C-31), 62.7 (C-62), 66.7 (C-42), 68.4 (C-11), 69.0 (C-52), 70.0 (C-32), 70.2 (C-22), 71.9 (C-21), 97.5
(C-12), 118.8 (C-51), 133.5 (C-41); anal. calcd for C46H40O12 (784.8): C, 70.40; H, 5.14; found: C, 70.37
H, 5.17.
3.14. 1-Dimethylthexylsilyloxy-4-pentene-3-ol 12
Thexyldimethylsilyl chloride (17.1 ml, 87.14 mmol) was added at 0°C to a solution of 114 (8.70
g, 85.18 mmol) and imidazole (14.50 g, 213.0 mmol) in CH2Cl2 (100 ml). The mixture was stirred
for 1 h, diluted with CH2Cl2, washed with aq. NaHCO3 solution, dried (Na2SO4) and concen-
trated. Chromatography (petroleum ether:ethyl acetate=15:1) of the residue afforded 12 (17.27 g,
1
83%); H NMR (250 MHz): δ=0.12 (s, 6H, Si(CH3)2), 0.85 (s, 6H, Si(CH3)2C(CH3)2), 0.89 (d, 6H,
Si(CH3)2C(CH3)2CH(CH3)2, J=6.9 Hz), 1.54–1.85 (m, 3H, Si(CH3)2C(CH3)2CH), 2-Ha, 2-Hb), 3.33 (d,
1H, OH, J=3.5 Hz), 3.78 (ddd, 1H, 1-Hb, J1b,2a=4.6 Hz, J1b,2b=7.2 Hz, J1a,1b=10.2 Hz), 3.88 (ddd, 1H,
1-Ha, J1a,2a=4.6 Hz), 4.31–4.40 (m, 1H, 3-H), 5.11 (dt, 1H, 5-Hcis, J4,5cis=10.4 Hz, J3,5cis=J5cis,5trans=1.6
Hz), 5.24 (dt, 1H, 5-Htrans, J4,5trans=17.2 Hz), 5.88 (ddd, 1H, 4-H, J3,4=5.4 Hz); 13C NMR (62.9 MHz):